Yannick Plétan est nommé directeur médical, responsable de la R&D clinique et des affaires médicales – Les Echos [FR]

January 2018. Yannick Plétan, 64 ans, titulaire d’un mastère en biologie humaine, est médecin pneumologue de formation.

Download full text article (PDF, French)

Read next in 'Media Coverage'

• Novel antiplatelet could circumvent bleeding risk for stroke patients
• Experimental antiplatelet compound for acute stroke shows promise
• New drug to prevent clots clears safety hurdle
• New blood thinner may prevent stroke, without risk for bleeding
• Acticor's blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke